Affinage

ELFN2

Protein phosphatase 1 regulatory subunit 29 · UniProt Q5R3F8

Length
820 aa
Mass
89.7 kDa
Annotated
2026-06-09
16 papers in source corpus 9 papers cited in narrative 9 extracted findings
Cross-family judge vs UniProt: Affinage preferred faithfulness: 5/5 claims corpus-supported (100%)

Mechanistic narrative

Synthesis pass · prose summary of the discoveries below

ELFN2 is a postsynaptic transmembrane adhesion molecule that organizes glutamatergic synapses by selectively binding all group III metabotropic glutamate receptors (mGluR4/6/7/8) in trans across the synaptic cleft and directly altering their G protein coupling kinetics and signaling efficacy (PMID:31485013, PMID:33790745). Its loss downregulates group III mGluRs and dysregulates synaptic transmission, producing seizure susceptibility, hyperactivity, and anxiety/compulsivity phenotypes in knockout mice that are reversed by pharmacological augmentation of group III mGluRs (PMID:31485013). In the retina, ELFN2 is selectively expressed in cone photoreceptors, where together with ELFN1 it transsynaptically recruits mGluR6 in ON-bipolar cells to specify cone-to-bipolar wiring and transmission (PMID:32879010). The trans-synaptic interaction depends on complex N-glycosylation of mGluR6 at N445, which is required for binding by the ELFN2 extracellular domain (PMID:38428819), and ELFN2 itself dimerizes through its extracellular leucine-rich repeat domain—forming homodimers and ELFN1 heterodimers prior to trafficking—while its intracellular juxtamembranous region directs membrane targeting and postsynaptic localization (PMID:39675706). Beyond the synapse, ELFN2 has been assigned roles as an adaptor that recruits the deubiquitinase CYLD to TAK1 to attenuate TLR-driven NF-κB and MAPK signaling (as LRRC62) (PMID:31301291) and as a binding partner of protein phosphatase-1 catalytic subunit alpha (PP1A) that blocks YAP Ser127 dephosphorylation to suppress gastric cancer metastasis (PMID:41967793).

Mechanistic history

Synthesis pass · year-by-year structured walk · 9 steps
  1. 2019 High

    Established ELFN2's core function: it was unknown how postsynaptic cues selectively shape group III mGluR signaling, and this work showed ELFN2 binds group III mGluRs in trans and tunes their G protein coupling, with loss causing defined synaptic and behavioral phenotypes.

    Evidence Transcellular GPCR signaling platform, Elfn2 KO mice, electrophysiology, behavioral assays, and pharmacological rescue

    PMID:31485013

    Open questions at the time
    • Structural basis of selective group III mGluR recognition not defined
    • Mechanism by which trans-binding alters G protein coupling kinetics unresolved
  2. 2020 High

    Resolved the cell-type-specific role in vision: it was unclear which adhesion molecule wires cone photoreceptors to ON-bipolar cells, and this work showed ELFN2 is cone-selective and acts with ELFN1 to recruit mGluR6 and enable cone synaptic transmission.

    Evidence Unbiased proteomics in cone-dominant species, conditional KO mice, immunolocalization, ERG, and ELFN1/ELFN2 genetic interaction

    PMID:32879010

    Open questions at the time
    • Division of labor between ELFN1 and ELFN2 at cone synapses incompletely defined
    • Developmental timing of ELFN2 recruitment not detailed
  3. 2021 Medium

    Consolidated cross-study evidence that postsynaptic ELFN2 regulates excitatory input broadly by recruiting presynaptic group III mGluRs across multiple brain circuits, generalizing the synaptic-organizer model.

    Evidence Review synthesizing transcellular signaling assays and KO models from multiple labs

    PMID:33790745

    Open questions at the time
    • Review-level synthesis rather than new primary data
    • Circuit-specific contributions of ELFN2 versus ELFN1 not delineated
  4. 2024 High

    Defined the molecular determinants of the trans-synaptic bond: it was unknown what makes the ELFN2-mGluR6 interaction specific, and this work showed complex N-glycosylation of mGluR6 at N445 is required for binding by the ELFN2 extracellular domain.

    Evidence Glycosidase treatment, pulldown with recombinant ELFN2 extracellular domain, site-directed mutagenesis, and localization assays in heterologous and bipolar cells

    PMID:38428819

    Open questions at the time
    • Structure of the glycan-dependent interface not solved
    • Whether other group III mGluRs require analogous glycosylation untested
  5. 2024 Medium

    Clarified how ELFN2 is built and trafficked: it was unknown how ELFN2 oligomerizes and reaches the postsynapse, and this work showed LRR-domain-mediated homo- and ELFN1-heterodimerization precedes trafficking, with a juxtamembranous intracellular motif controlling membrane targeting.

    Evidence Domain deletion/mutagenesis, co-IP, subcellular fractionation, live-cell imaging, and postsynaptic localization assays

    PMID:39675706

    Open questions at the time
    • Single-lab structural inference without crystallographic confirmation
    • Functional consequence of homo- versus heterodimer composition at synapses unknown
  6. 2018 Medium

    Implicated ELFN2 in a non-synaptic role: in glioblastoma cells it interacts with Aurora kinase A and eIF2α to promote autophagy, with expression controlled by promoter hypomethylation, miR-101, and lncRNA LINC00470.

    Evidence Co-IP, overexpression/knockdown in GBM lines, autophagy assays, methylation analysis, and ChIP

    PMID:30037656

    Open questions at the time
    • Mechanism linking AurkA inhibition to autophagy not detailed
    • Relationship to ELFN2's synaptic adhesion function unclear
  7. 2019 Medium

    Identified an immune signaling role: as LRRC62, ELFN2 acts as an adaptor recruiting the deubiquitinase CYLD to TAK1, promoting K63 deubiquitination and dampening TLR-driven NF-κB and MAPK signaling.

    Evidence Co-IP, overexpression/knockdown, cytokine assays, and ubiquitination assays

    PMID:31301291

    Open questions at the time
    • Single-lab characterization without in vivo immune validation
    • How a transmembrane adhesion protein engages cytosolic TAK1/CYLD not reconciled
  8. 2026 Medium

    Linked ELFN2 to cancer signaling: it binds PP1A and blocks dephosphorylation of YAP at Ser127, driving YAP nuclear export and suppressing gastric cancer lymph node metastasis.

    Evidence Co-IP, phosphorylation assays, PP1A inhibitor pharmacology, and in vivo metastasis models

    PMID:41967793

    Open questions at the time
    • Single-lab, abstract-level mechanistic detail
    • Whether PP1A inhibition is direct competition or allosteric not resolved
  9. 2026 Low

    Probed the developmental interdependence of the synaptic partners: ablating mGluR6 before synaptogenesis mislocalizes ELFN2 at cone pedicles, indicating mGluR6 is needed for proper ELFN2 positioning during human retinal circuit assembly.

    Evidence CRISPR ablation in human iPSC-derived retinal organoids with immunofluorescence localization (preprint)

    PMID:42094404

    Open questions at the time
    • Preprint, immunolocalization only without functional follow-up for ELFN2
    • Whether mislocalization reflects loss of trans-binding or upstream defect untested

Open questions

Synthesis pass · forward-looking unresolved questions
  • How ELFN2's disparate roles—synaptic group III mGluR organization versus cytosolic regulation of TAK1, PP1A, and AurkA—are reconciled mechanistically and whether they reflect distinct contexts of a single protein remains unresolved.
  • No structural model of ELFN2 or its complexes
  • No unifying account of how a transmembrane adhesion molecule accesses intracellular signaling partners

Mechanism profile

Synthesis pass · controlled-vocabulary classification · explore literature graph →
Molecular activity
GO:0060090 molecular adaptor activity 2 GO:0098631 cell adhesion mediator activity 2 GO:0098772 molecular function regulator activity 2
Localization
GO:0005886 plasma membrane 2
Pathway
R-HSA-112316 Neuronal System 2 R-HSA-162582 Signal Transduction 2

Evidence

Reading pass · 9 per-paper findings extracted from the source corpus
Year Finding Method Journal Conf PMIDs
2019 ELFN2 is a postsynaptic adhesion molecule that selectively binds group III metabotropic glutamate receptors (mGluR4, mGluR6, mGluR7, mGluR8) in trans across the synapse, directly alters G protein coupling kinetics and efficacy of group III mGluRs, and its loss results in selective downregulation of group III mGluRs and dysregulated glutamatergic synaptic transmission. Elfn2 KO mice display seizure susceptibility, hyperactivity, and anxiety/compulsivity rescued by pharmacological augmentation of group III mGluRs. Transcellular GPCR signaling platform, Elfn2 knockout mice, electrophysiology, behavioral assays, pharmacological rescue Molecular psychiatry High 31485013
2020 ELFN2 is selectively expressed in cone photoreceptors (not rods) and transsynaptically recruits mGluR6 in ON-bipolar cells to enable cone synaptic transmission. ELFN2 functions in synergy with ELFN1 during development to specify selective wiring and transmission of cone signals to ON-type bipolar cells. Unbiased proteomics in cone-dominant species, conditional knockout mice, immunolocalization, electrophysiology (ERG), and genetic interaction (ELFN1/ELFN2 double mutants) Proceedings of the National Academy of Sciences of the United States of America High 32879010
2018 In GBM cells, ELFN2 promotes autophagy by interacting with Aurora kinase A (AurkA) and eIF2α and inhibiting AurkA activation. ELFN2 expression is epigenetically regulated by promoter hypomethylation, miR-101 downregulation, and the lncRNA LINC00470 (which adsorbs miR-101 and decreases H3K27me3 occupancy at the ELFN2 promoter). Co-immunoprecipitation, overexpression/knockdown in GBM cell lines, autophagy assays, methylation analysis, chromatin immunoprecipitation Molecular therapy : the journal of the American Society of Gene Therapy Medium 30037656
2019 LRRC62 (ELFN2 alias) functions as an adaptor protein that recruits the deubiquitinase CYLD to TAK1, thereby promoting K63-linked deubiquitination and inactivation of TAK1, resulting in negative regulation of TLR-induced NF-κB and MAPK signaling and reduced pro-inflammatory cytokine production. Co-immunoprecipitation, overexpression and knockdown in cell lines, cytokine production assays, ubiquitination assays Experimental cell research Medium 31301291
2024 Complex N-glycosylation of mGluR6 is required for its trans-synaptic interaction with ELFN2 (and ELFN1). Pull-down experiments with ELFN2 extracellular domains showed interaction exclusively with complex-glycosylated mGluR6. Mutation at N445 of mGluR6 severely impaired ELFN2 binding. N-glycosylation at N445 is sufficient but not necessary for dendritic tip localization of mGluR6. Glycosidase treatment (PNGase F, Endo H), pulldown assays with ELFN2 extracellular domain, site-directed mutagenesis of N-glycosylation sites, surface expression and localization assays in heterologous cells and rod bipolar cells The Journal of biological chemistry High 38428819
2024 ELFN2 forms homodimers prior to membrane trafficking, utilizing the extracellular leucine-rich repeat (LRR) domain for dimerization. ELFN2 also participates in heterodimerization with ELFN1. The intracellular domain controls membrane targeting and postsynaptic localization, with a ~30 amino acid juxtamembranous region required for membrane-targeting, and a single membrane-targeting motif in one protomer is sufficient for trafficking of the homodimer. Domain deletion/mutagenesis, co-immunoprecipitation for dimerization, subcellular fractionation, live-cell imaging, postsynaptic localization assays The Journal of biological chemistry Medium 39675706
2026 ELFN2 interacts directly with the catalytic subunit alpha of protein phosphatase-1 (PP1A) and inhibits PP1A-mediated dephosphorylation of YAP at Ser127, thereby promoting YAP nuclear export and functional inactivation, suppressing lymph node metastasis in gastric cancer. Pharmacological inhibition of PP1A abrogated ELFN2-induced YAP inactivation. Co-immunoprecipitation, phosphorylation assays, PP1A inhibitor pharmacology, in vivo metastasis models (lymph node and peritoneal carcinomatosis) Experimental cell research Medium 41967793
2021 ELFN2 (and ELFN1) can interact in trans with all group III mGluRs (mGluR4, mGluR6, mGluR7, mGluR8) and alter mGluR-mediated signaling through these trans-interactions. Postsynaptic ELFN2 in the brain mediates regulation of excitatory input through recruitment of presynaptic group III mGluRs. Review synthesizing results from multiple studies including transcellular signaling assays and KO models (mechanistic synthesis/review article citing primary data) Frontiers in neural circuits Medium 33790745
2026 ELFN2 is mislocalized at cone pedicles when mGluR6 is ablated prior to synaptogenesis during human retinal development (in iPSC-derived organoids), indicating that mGluR6 is required for proper ELFN2 localization during circuit assembly. CRISPR-based genetic ablation in human iPSC-derived retinal organoids, immunofluorescence localization bioRxiv : the preprint server for biologypreprint Low 42094404

Source papers

Stage 0 corpus · 16 papers · ranked by NIH iCite citations
Year Title Journal Citations PMID
2014 Unbiased analysis of pancreatic cancer radiation resistance reveals cholesterol biosynthesis as a novel target for radiosensitisation. British journal of cancer 92 25025965
2017 DNA-Methylation and Body Composition in Preschool Children: Epigenome-Wide-Analysis in the European Childhood Obesity Project (CHOP)-Study. Scientific reports 58 29084944
2018 LINC00470 Coordinates the Epigenetic Regulation of ELFN2 to Distract GBM Cell Autophagy. Molecular therapy : the journal of the American Society of Gene Therapy 57 30037656
2020 Interplay between cell-adhesion molecules governs synaptic wiring of cone photoreceptors. Proceedings of the National Academy of Sciences of the United States of America 39 32879010
2023 Single-cell RNA-seq uncovers dynamic processes orchestrated by RNA-binding protein DDX43 in chromatin remodeling during spermiogenesis. Nature communications 37 37120627
2019 ELFN2 is a postsynaptic cell adhesion molecule with essential roles in controlling group III mGluRs in the brain and neuropsychiatric behavior. Molecular psychiatry 31 31485013
2017 Overexpression of CST4 promotes gastric cancer aggressiveness by activating the ELFN2 signaling pathway. American journal of cancer research 28 29218251
2021 Trans-Synaptic Regulation of Metabotropic Glutamate Receptors by Elfn Proteins in Health and Disease. Frontiers in neural circuits 19 33790745
2014 Novel candidate genes putatively involved in stress fracture predisposition detected by whole-exome sequencing. Genetics research 13 25023003
2024 Complex N-glycosylation of mGluR6 is required for trans-synaptic interaction with ELFN adhesion proteins. The Journal of biological chemistry 9 38428819
2024 Cone Synaptic Function is Modulated by the Leucine-Rich Repeat Adhesion Molecule LRFN2. eNeuro 5 38408870
2024 Distinct autoregulatory roles of ELFN1 intracellular and extracellular domains on membrane trafficking, synaptic localization, and dimerization. The Journal of biological chemistry 5 39675706
2019 LRRC62 attenuates Toll-like receptor signaling by deubiquitinating TAK1 via CYLD. Experimental cell research 3 31301291
2026 ELFN2 inhibits YAP-driven lymph node metastasis in gastric cancer by blocking PP1A-mediated dephosphorylation. Experimental cell research 0 41967793
2026 mGluR6 coordinates cone terminal targeting and synaptic layer assembly during human retinal development. bioRxiv : the preprint server for biology 0 42094404
2025 Profiling the Impact of mGlu7/Elfn1 Protein Interactions on the Pharmacology of mGlu7 Allosteric Modulators. ACS chemical neuroscience 0 40689847

Missed literature

Know a paper Affinage missed for ELFN2? Flag it for the maintainers and the community.

No submissions yet.